Publication Date: July 29, 2024 Published By: Haute Living Article  Link: https://hauteliving.com/2024/07/terminal-thriving-real-patient-outcomes-neoncs-treatment/754697/ NeOnc Executive Team: (l-r) Patrick Walters, Dr. Thomas Chen, Amir Heshmatpour, Keithly Garnett Clinical trials might not seem too exciting to the average person. However, when the medication being evaluated (or, in this case, NeOnc’s drug delivery system) has the potential to treat […]

Publication Date: July 25, 2024 Published By: Pharma Insider Article  Link: https://www.mediapost.com/publications/article/397827/neonc-noses-into-novel-brain-cancer-treatment.html Treatment for brain cancer patients typically consists of surgery, radiation, and an oral drug called Temozolomide, developed by Merck and now generic. The most serious cases, however, still have less than a three-month survival rate, Dr. Thomas Chen, director of surgical neuro-oncology at […]

Publication Date: July 15, 2024 Published By: Media Daily Article  Link: https://www.medicaldaily.com/healing-home-how-neoncs-innovative-treatment-brings-brain-cancer-care-patients-doorsteps-471965 Dr. Thomas Chen Brain cancer treatment has remained static for years because of the difficulty of getting drugs past the blood-brain barrier. That could be about to change thanks to NeOnc‘s innovative non-invasive nasal brain delivery system for brain cancer drugs. Dr. Thomas Chen, […]

Publication Date: July 15, 2024 Published By: Venture Capital Post Article  Link: https://www.vcpost.com/articles/128094/20240715/neoncs-unique-path-to-ipo-a-biotech-game-changer.htm NeOnc Executive Team: (l-r) Pat Walters, Dr. Thomas Chen, Amir Heshmatpour, Keithly A. Garnett NeOnc, Technologies Holdings, Inc., a biotech company revolutionizing the treatment of brain cancer with its innovative delivery method, is breaking new ground once again by closing its most […]

Publication Date: July 12, 2024 Published By: LA Weekly Article  Link: https://www.laweekly.com/revolutionizing-brain-cancer-treatment-neonc-introduces-first-non-invasive-intranasal-drug-delivery-for-brain-cancer/ NeOnc President Amir F. Heshmatpour and CEO Dr. Thomas Chen   NeOnc, a biotech company helmed by Dr. Thomas Chen, brings the first non-invasive intranasal drug delivery for brain cancer into the spotlight. With this revolutionary treatment, NeOnc is poised to change the […]

Publication Date: July 10, 2024 Published By: Meditech Today Article  Link: https://meditechtoday.com/neoncs-breakthrough-in-brain-cancer-care/ NeOnc Founder and CEO Dr. Thomas Chen Brain cancer is always a devastating diagnosis. And despite decades of research into cancer treatment, patients with some types of brain tumors only have months to live. Now, thanks to a new development by biotech company NeOnc, there […]